Renaparin® in Kidney Transplantation

Summary

This study evaluates the safety and tolerability of Renaparin in adult patients receiving a deceased donor kidney treated ex-vivo with Renaparin prior to transplantation. Half the patient group will receive a kidney treated with Renaparin, while the other half of the patient group will receive a kidney treated with placebo.

Timeline

Start

2019-02-14

Primary completion

2020-04-21

Completion

2020-04-21

Outcome

Met primary endpoint

release “Vi konstaterar att Renaparin ® uppvisar bra resultat avseende både primära och sekundära endpoints i fas 1.” globenewswire.com ↗

Drugs

Indications

No indication recorded.